Study of the Possibility of Detecting Optical Inhomogeneities in Brain Tissues from Images in the Visible and Near Infrared Ranges

Author(s):  
S. A. Yushina ◽  
N. N. Kuznetsov ◽  
A. V. Kolpakov
Keyword(s):  
2002 ◽  
Vol 47 (12) ◽  
pp. 2059-2073 ◽  
Author(s):  
A N Yaroslavsky ◽  
P C Schulze ◽  
I V Yaroslavsky ◽  
R Schober ◽  
F Ulrich ◽  
...  

2014 ◽  
Author(s):  
Hiroaki Suzuki ◽  
Motoki Oda ◽  
Etsuko Yamaki ◽  
Toshihiko Suzuki ◽  
Daisuke Yamashita ◽  
...  

2020 ◽  
Vol 22 (Supplement_2) ◽  
pp. ii51-ii52
Author(s):  
Quan Zhou ◽  
Nynke van den Berg ◽  
Naoki Nishio ◽  
Guolan Lu ◽  
Stefania Chirita ◽  
...  

Abstract INTRODUCTION High-grade gliomas (HGGs) are malignant brain tumors with devastating prognosis. Extent of resection predicts survival in patients, but current neuroimaging approaches lack tumor specificity. The epidermal growth factor receptor (EGFR) is a biomarker heterogeneously expressed in HGGs. We assessed the feasibility of imaging HGGs using a near-infrared fluorescent anti-EGFR antibody. METHODS Nine patients with contrast enhancing HGGs on presurgical MRI scan were systemically infused with a flat dose of either 50mg (n = 4) or 100mg (n = 5) panitumumab-IRDye800, 1–5 days before surgery. Near-infrared fluorescence imaging of tumor and histologically normal brain tissues was performed intraoperatively and ex vivo. Fluorescence was measured as mean fluorescence intensity (MFI), and tumor-to-background ratio (TBR) were calculated by comparing MFIs of tumor and histologically uninvolved tissue. Immunohistopathological staining of EGFR was performed on formalin fixed paraffin embedded tissue sections. RESULTS Both MFI and TBR were positively correlated to panitumumab-IRDye800 dose per body weight (R2 = 0.59 and 0.07, P < 0.0001 and P = 0.046 respectively). The TBR was higher at a 100 mg dose than at 50 mg (2.1 vs. 1.5). The smallest detectable tumor volume in a closed-field setting was 21 mg with 50 mg of dye and 12 mg with 100 mg. On sections of paraffin embedded tissues, positive EGFR protein expression was observed in 88.9% ± 12.4% of tumor tissues and positively correlated with fluorescence. Sensitivity and specificity of tumor fluorescence for viable tumor detection was calculated and fluorescence was found to be highly sensitive (93%) and specific (81%) for viable tumor tissues while normal brain tissues showed minimal fluorescence. No adverse events related to the imaging probe was observed. CONCLUSION This first-in-human study demonstrates the feasibility and safety of antibody based imaging for contrast enhancing high-grade gliomas.


1992 ◽  
Vol 141 (1) ◽  
pp. 47-52 ◽  
Author(s):  
Aritake Mizuno ◽  
Takashi Hayashi ◽  
Kouichi Tashibu ◽  
Shuichi Maraishi ◽  
Kazuaki Kawauchi ◽  
...  

2006 ◽  
Author(s):  
Korhan Özer ◽  
Özgüncem Bozkulak ◽  
Haşim Özgür Tabakoğlu ◽  
Adnan Kurt ◽  
Murat Gülsoy

2021 ◽  
Vol 118 (45) ◽  
pp. e2106143118
Author(s):  
Ming-Yu Wu ◽  
Alex Y. H. Wong ◽  
Jong-Kai Leung ◽  
Chuen Kam ◽  
Kenneth Lap-Kei Wu ◽  
...  

Myelin, the structure that surrounds and insulates neuronal axons, is an important component of the central nervous system. The visualization of the myelinated fibers in brain tissues can largely facilitate the diagnosis of myelin-related diseases and understand how the brain functions. However, the most widely used fluorescent probes for myelin visualization, such as Vybrant DiD and FluoroMyelin, have strong background staining, low-staining contrast, and low brightness. These drawbacks may originate from their self-quenching properties and greatly limit their applications in three-dimensional (3D) imaging and myelin tracing. Chemical probes for the fluorescence imaging of myelin in 3D, especially in optically cleared tissue, are highly desirable but rarely reported. We herein developed a near-infrared aggregation-induced emission (AIE)-active probe, PM-ML, for high-performance myelin imaging. PM-ML is plasma membrane targeting with good photostability. It could specifically label myelinated fibers in teased sciatic nerves and mouse brain tissues with a high–signal-to-background ratio. PM-ML could be used for 3D visualization of myelin sheaths, myelinated fibers, and fascicles with high-penetration depth. The staining is compatible with different brain tissue–clearing methods, such as ClearT and ClearT2. The utility of PM-ML staining in demyelinating disease studies was demonstrated using the mouse model of multiple sclerosis. Together, this work provides an important tool for high-quality myelin visualization across scales, which may greatly contribute to the study of myelin-related diseases.


Sign in / Sign up

Export Citation Format

Share Document